USE OF KETAMINE IN SEVERE STATUS ASTHMATICUS IN INTENSIVE CARE UNIT

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HESHMATI F.; ZEYNALI M.B.; NOUROUZINIA H.; ABBASIVASH R.; MAHOURI A.R.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Allergy, Asthma and Immunology Year:2003 | Volume:2 | Issue:4 Page(s): 175-180

Download Full-Text

View:

515

Download:

281

Cites:

Information Journal Paper

Title

USE OF KETAMINE IN SEVERE STATUS ASTHMATICUS IN INTENSIVE CARE UNIT

Author(s)

Keywords

INTENSIVE CARE UNIT

KETAMINE

STATUS ASTHMATICUS

Abstract

Bronchial asthma represents an increased airways responsiveness to various stimulants, leading to reversible obstruction of expiratory flow and chronic inflammatory changes in airways wall. KETAMINE has been demonstrated to lower airway resistance and to increase lung compliance in the asthmatic patients. In several studies and case reports it has been used successfully in the management of STATUS ASTHMATICUS, resistant to conventional therapy, but so far no clinical trial has been carried out to support this empirical use of KETAMINE. For this reason, we designed a prospective observational study. Eleven, 15-40 years old patients, with STATUS ASTHMATICUS whose respiratory failure did not respond to conventional therapy and mechanical ventilation (after 24h), were entered in this study (provided that there were not any contraindications to KETAMINE use). These patients received KETAMINE at a loading dose of 1 mg/kg (IV), followed by a continuous infusion of 1 mg/kg/hr for 2h. Peak airway pressure, PaCO2 and PaO2 were measured prior to KETAMINE administration, 15min after administration and 2h after infusion of KETAMINE. Mean peak airway pressure and PaCO2 significantly decreased 15min and 2h after administration and infusion of KETAMINE (p<0.005) and PaO2 significantly increased in these time intervals (p<0.005).Ketamine is a useful and safe drug in the intensive treatment of STATUS ASTHMATICUS. However, KETAMINE should only be used for asthmatics whose respiratory failure does not respond to standard therapy.

Cites

No record.

References

No record.

Cite

APA: Copy

HESHMATI, F., ZEYNALI, M.B., NOUROUZINIA, H., ABBASIVASH, R., & MAHOURI, A.R.. (2003). USE OF KETAMINE IN SEVERE STATUS ASTHMATICUS IN INTENSIVE CARE UNIT. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), 2(4), 175-180. SID. https://sid.ir/paper/291049/en

Vancouver: Copy

HESHMATI F., ZEYNALI M.B., NOUROUZINIA H., ABBASIVASH R., MAHOURI A.R.. USE OF KETAMINE IN SEVERE STATUS ASTHMATICUS IN INTENSIVE CARE UNIT. IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI)[Internet]. 2003;2(4):175-180. Available from: https://sid.ir/paper/291049/en

IEEE: Copy

F. HESHMATI, M.B. ZEYNALI, H. NOUROUZINIA, R. ABBASIVASH, and A.R. MAHOURI, “USE OF KETAMINE IN SEVERE STATUS ASTHMATICUS IN INTENSIVE CARE UNIT,” IRANIAN JOURNAL OF ALLERGY, ASTHMA AND IMMUNOLOGY (IJAAI), vol. 2, no. 4, pp. 175–180, 2003, [Online]. Available: https://sid.ir/paper/291049/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops